• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[双相诊断患者(身体变形障碍和躯体型妄想障碍)的长期观察结果(3至11年)]

[Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type].

作者信息

Rabe-Jabłońska J

机构信息

II Kliniki Psychiatrycznej Katedry Psychiatrii AM w Lodzi.

出版信息

Psychiatr Pol. 1998 Mar-Apr;32(2):143-53.

PMID:9640983
Abstract

This work presents results of a retrospective and prospective research of 15 persons with a double diagnosis: body dysmorphic disorder, and delusional disorder, somatic type. It was established that these disorders starting in adolescence, occurred in persons who earlier had traits of avoidant and obsessive-compulsive personality or social phobia. In most subjects with dysmorphophobia there was comorbidity of dysthymia or major depression. An improvement in the state of these patients, most often after implementation of complex therapeutic measures: psychotherapy as well as pharmacotherapy with neuroleptic and SSRI's or clomipramine has to do with withdrawal of delusions, whereas the symptoms of body dysmorphic disorder usually last for years. In some patients delusional disorders had a tendency to reoccur or to be chronic, and lead to a considerable impairment of social functioning.

摘要

这项研究呈现了对15名患有双重诊断(身体变形障碍和躯体型妄想障碍)患者的回顾性和前瞻性研究结果。研究发现,这些始于青春期的疾病发生在早期具有回避型、强迫型人格特质或社交恐惧症的人群中。在大多数患有畸形恐惧症的受试者中,存在心境恶劣或重度抑郁的共病情况。这些患者状况的改善,多数是在实施综合治疗措施(心理治疗以及使用抗精神病药物、选择性5-羟色胺再摄取抑制剂或氯米帕明进行药物治疗)之后,这与妄想的消除有关,而身体变形障碍的症状通常会持续数年。在一些患者中,妄想障碍有复发或慢性化的倾向,并导致相当程度的社会功能损害。

相似文献

1
[Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type].[双相诊断患者(身体变形障碍和躯体型妄想障碍)的长期观察结果(3至11年)]
Psychiatr Pol. 1998 Mar-Apr;32(2):143-53.
2
Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.氯米帕明与地昔帕明治疗躯体变形障碍的交叉试验:5-羟色胺再摄取抑制剂对想象丑陋的选择性疗效
Arch Gen Psychiatry. 1999 Nov;56(11):1033-9. doi: 10.1001/archpsyc.56.11.1033.
3
Efficacy and safety of fluvoxamine in body dysmorphic disorder.氟伏沙明治疗躯体变形障碍的疗效与安全性。
J Clin Psychiatry. 1998 Apr;59(4):165-71. doi: 10.4088/jcp.v59n0404.
4
Dysmorphophobia: body dysmorphic disorder or delusional disorder, somatic subtype?畸形恐惧症:身体变形障碍还是妄想障碍,躯体亚型?
Compr Psychiatry. 1989 Nov-Dec;30(6):457-72. doi: 10.1016/0010-440x(89)90075-8.
5
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.躯体变形障碍中的妄想症及对开放标签氟伏沙明的反应
J Clin Psychiatry. 2001 Feb;62(2):87-91. doi: 10.4088/jcp.v62n0203.
6
Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.在躯体变形障碍中使用匹莫齐特增强氟西汀疗效的安慰剂对照研究。
Am J Psychiatry. 2005 Feb;162(2):377-9. doi: 10.1176/appi.ajp.162.2.377.
7
[Body dysmorphic disorder: clinical picture, diagnostic criteria, prevalence, course and treatment].[躯体变形障碍:临床表现、诊断标准、患病率、病程及治疗]
Psychiatr Pol. 1998 Mar-Apr;32(2):133-42.
8
An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.一项关于帕罗西汀治疗“冒犯型”恐人症和社交焦虑障碍的开放性试验。
Depress Anxiety. 2006;23(3):168-74. doi: 10.1002/da.20153.
9
Obsessive-compulsive disorder in relation to body dysmorphic disorder.与躯体变形障碍相关的强迫症
Am J Psychiatry. 1992 Sep;149(9):1283-4. doi: 10.1176/ajp.149.9.1283.
10
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.一项关于氟西汀治疗躯体变形障碍的随机安慰剂对照试验。
Arch Gen Psychiatry. 2002 Apr;59(4):381-8. doi: 10.1001/archpsyc.59.4.381.